This article discusses the differences and similarities between nivolumab subcutaneous injections and IV infusions for RCC to help people make the most suitable decisions for their treatment.

HyQvia is the only up to once monthly (every 2, 3 or 4 weeks) immunoglobulin subcutaneous infusion to treat CIDP in Canada TORONTO, March 27, 2025 /CNW/ - Takeda Canada Inc. (Takeda) is pleased to ...

Subcutaneous injections offer various potential benefits over intravenous infusions. In general, these types of injections are faster and easier than infusions. Infusions typically take place ...

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the ...

Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy Keytruda in the U.S. on October 1, and expects to hit peak adoption rates ...

it said the median injection time per subcutaneous dose was two minutes, down from around 30 minutes for a Keytruda infusion. Merck has relied on Keytruda to fuel its growth for years. It hopes ...